Skip to main content

Advertisement

Log in

Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

The association between a newly identified CA repeat polymorphism of the estrogen receptor alpha gene (ESR1) with osteoporosis was investigated. Postmenopausal women with <18 CA repeats had low BMD, increased rate of bone loss and increased fracture risk.

Introduction

Studies have shown that intronic dinucleotide repeat polymorphisms in some genes are associated with disease risk by modulating mRNA splicing efficiency. D6S440 is a newly identified intronic CA repeat polymorphism located downstream of the 5’-splicing site of exon 5 of ESR1.

Methods

The associations of D6S440 with bone mineral density (BMD), rate of bone loss and fracture risk were evaluated in 452 pre-, 110 peri- and 622 postmenopausal southern Chinese women using regression models.

Results

Post- but not premenopausal women with less CA repeats had lower spine and hip BMD. The number of CA repeats was linearly related to hip BMD in postmenopausal women (β = 0.008; p = 0.004). Postmenopausal women with CA repeats <18 had higher risks of having osteoporosis (BMD T-score<−2.5 at the spine: OR 2.46, 95% CI 1.30–4.65; at the hip: OR 3.79(1.64–8.74)) and low trauma fractures (OR 2.31(1.29–4.14)) than those with ≥18 repeats. Perimenopausal women with <18 CA repeats had significantly greater bone loss in 18 months at the hip than those with ≥18 repeats (−1.96% vs. −1.61%, p = 0.029).

Conclusions

ESR1 CA repeat polymorphism is associated with BMD variation, rate of bone loss and fracture risk, and this may be a useful genetic marker for fracture risk assessment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302

    Article  PubMed  CAS  Google Scholar 

  2. Lee K, Jessop H, Suswillo R et al (2003) Endocrinology: bone adaptation requires oestrogen receptor-alpha. Nature 424:389

    Article  PubMed  CAS  Google Scholar 

  3. Penolazzi L, Lambertini E, Giordano S et al (2004) Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells. J Steroid Biochem Mol Biol 91:1–9

    Article  PubMed  CAS  Google Scholar 

  4. Waters KM, Rickard DJ, Riggs BL et al (2001) Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J Cell Biochem 83:448–462

    Article  PubMed  CAS  Google Scholar 

  5. Gallagher A, Chambers TJ, Tobias JH (1993) The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats. Endocrinology 133:2787–2791

    Article  PubMed  CAS  Google Scholar 

  6. Syed F, Khosla S (2005) Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688–696

    Article  PubMed  CAS  Google Scholar 

  7. Cheng MZ, Rawlinson SC, Pitsillides AA et al (2002) Human osteoblasts’ proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I. J Bone Miner Res 17:593–602

    Article  PubMed  CAS  Google Scholar 

  8. Di Gregorio GB, Yamamoto M, Ali AA et al (2001) Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol. J Clin Invest 107:803–812

    Article  PubMed  Google Scholar 

  9. Jessop HL, Suswillo RF, Rawlinson SC et al (2004) Osteoblast-like cells from estrogen receptor alpha knockout mice have deficient responses to mechanical strain. J Bone Miner Res 19:938–946

    Article  PubMed  CAS  Google Scholar 

  10. Riggs BL, Khosla S, Atkinson EJ et al (2003) Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency. Osteoporos Int 14:728–733

    Article  PubMed  CAS  Google Scholar 

  11. Smith EP, Boyd J, Frank GR et al (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056–1061

    Article  PubMed  CAS  Google Scholar 

  12. Ioannidis JP, Ralston SH, Bennett ST et al (2004) Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. Jama 292:2105–2114

    Article  PubMed  CAS  Google Scholar 

  13. Gennari L, Merlotti D, De Paola V et al (2005) Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. A J Epidemiol 161:307–320

    Article  CAS  Google Scholar 

  14. Kobayashi N, Fujino T, Shirogane T et al (2002) Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 41:193–201

    Article  PubMed  CAS  Google Scholar 

  15. Sowers M, Jannausch ML, Liang W et al (2004) Estrogen receptor genotypes and their association with the 10-year changes in bone mineral density and osteocalcin concentrations. J Clin Endocrinol Metab 89:733–739

    Article  PubMed  CAS  Google Scholar 

  16. Langdahl BL, Lokke E, Carstens M et al (2000) A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not. J Bone Miner Res 15:2222–2230

    Article  PubMed  CAS  Google Scholar 

  17. Hui J, Stangl K, Lane WS et al (2003) HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats. Nat Struct Biol 10:33–37

    Article  PubMed  CAS  Google Scholar 

  18. Genant HK, Wu CY, van Kuijk C et al (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148

    Article  PubMed  CAS  Google Scholar 

  19. Zhao JH (2004) 2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis. Bioinformatics (Oxford, England) 20:1325–1326

    Article  CAS  Google Scholar 

  20. Ralston SH, Galwey N, MacKay I et al (2005) Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. Hum Mol Genet 14:943–951

    Article  PubMed  CAS  Google Scholar 

  21. Hoyland JA, Mee AP, Baird P et al (1997) Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. Bone 20:87–92

    Article  PubMed  CAS  Google Scholar 

  22. Damien E, Price JS, Lanyon LE (2000) Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females. J Bone Miner Res 15:2169–2177

    Article  PubMed  CAS  Google Scholar 

  23. Windahl SH, Andersson G, Gustafsson JA (2002) Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab: TEM 13:195–200

    Article  PubMed  CAS  Google Scholar 

  24. Albagha OM, Pettersson U, Stewart A et al (2005) Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet 42:240–246

    Article  PubMed  CAS  Google Scholar 

  25. Bustamante M, Nogues X, Enjuanes A et al (2007) COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women. Osteoporos Int 18:235–243

    Article  PubMed  CAS  Google Scholar 

  26. Choi JY, Shin A, Park SK et al (2005) Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Calcif Tissue Int 77:152–159

    Article  PubMed  CAS  Google Scholar 

  27. Greendale GA, Chu J, Ferrell R et al (2006) The association of bone mineral density with estrogen receptor gene polymorphisms. Am J Med 119:S79–S86

    Article  PubMed  CAS  Google Scholar 

  28. Rivadeneira F, van Meurs JB, Kant J et al (2006) Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res 21:1443–1456

    Article  PubMed  CAS  Google Scholar 

  29. van Meurs JB, Schuit SC, Weel AE et al (2003) Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet 12:1745–1754

    Article  CAS  Google Scholar 

  30. Becherini L, Gennari L, Masi L et al (2000) Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet 9:2043–2050

    Article  PubMed  CAS  Google Scholar 

  31. Ho AY, Yeung SS, Kung AW (2000) PvuII polymorphisms of the estrogen receptor alpha and bone mineral density in healthy southern Chinese women. Calcif Tissue Int 66:405–408

    Article  PubMed  CAS  Google Scholar 

  32. Lau HH, Ng MY, Cheung WM et al (2006) Assessment of linkage and association of 13 genetic loci with bone mineral density. J Bone Min Metab 24:226–234

    Article  CAS  Google Scholar 

  33. Lau HH, Ng MY, Ho AY et al (2005) Genetic and environmental determinants of bone mineral density in Chinese women. Bone 36:700–709

    Article  PubMed  CAS  Google Scholar 

  34. Bagger YZ, Jorgensen HL, Heegaard AM et al (2000) No major effect of estrogen receptor gene polymorphisms on bone mineral density or bone loss in postmenopausal Danish women. Bone 26:111–116

    Article  PubMed  CAS  Google Scholar 

  35. Han K, Choi J, Moon I et al (1999) Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women. Osteoporos Int 9:290–295

    Article  PubMed  CAS  Google Scholar 

  36. Wang CL, Tang XY, Chen WQ et al (2007) Association of estrogen receptor alpha gene polymorphisms with bone mineral density in Chinese women: a meta-analysis. Osteoporos Int 18:295–305

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank the staff of the Osteoporosis Centre at Queen Mary Hospital and KS Lau for technical support. This project is supported by CRCG Grant, Bone Health Fund, The Matching Grant and The Osteoporosis and Endocrine Research Fund of the University of Hong Kong.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. W. C. Kung.

Additional information

Funding Source: This project is supported by CRCG Grant, Bone Health Fund, Matching Grant and Osteoporosis and Endocrine Research Fund of the University of Hong Kong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lai, B.M.H., Cheung, C.L., Luk, K.D.K. et al. Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women. Osteoporos Int 19, 571–579 (2008). https://doi.org/10.1007/s00198-007-0482-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-007-0482-1

Keywords

Navigation